tiprankstipranks
Holding GB:MRN3?
Track your performance easily

GB:MRN3 Technical Analysis

Summary of all the Indicators

Summary
Sell
6Bullish
2Neutral
14Bearish
Oscillators
Buy
5Bullish
2Neutral
3Bearish
Moving Averages
Strong Sell
1Bullish
0Neutral
11Bearish
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Leverage Shares 3x Long Moderna (MRNA) ETP Securities is a Buy.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 20-Day exponential moving average is 0.16, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-Day exponential moving average is 0.43, making it a Sell.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Pivot Points

Jan 22, 2025, 03:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.08
0.08
0.08
0.09
0.09
0.10
0.10
Fibonacci
0.08
0.08
0.08
0.09
0.09
0.09
0.10

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Moving Averages

Jan 22, 2025, 03:58 PM
Period
Simple
Exponential
MA5
0.08Buy
0.09Sell
MA10
0.12Sell
0.12Sell
MA20
0.17Sell
0.16Sell
MA50
0.22Sell
0.43Sell
MA100
0.68Sell
1.81Sell
MA200
7.60Sell
6.24Sell
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 10-Day exponential moving average is 0.12, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-Day exponential moving average is 1.81, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-day simple moving average is 0.22, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-day simple moving average is 0.68, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 200-day simple moving average is 7.60, creating a Sell signal.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Technical Analysis

Jan 22, 2025, 03:58 PM
Name
Value
Action
RSI (14)
35.04
Neutral
STOCH (9,6)
5.47
Buy
STOCHRSI (14)
4.40
Buy
MACD (12,26)
-0.06
Buy
ADX (14)
14.85
Buy
Williams %R
-95.60
Buy
CCI (14)
-93.78
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
24.78
Sell
ROC
-57.89
Sell
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Relative Strength Index (RSI) is 35.04, creating a Neutral signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Trend Strength Indicator (ADX) is 14.85, creating a Buy signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Commodity Channel Index (CCI) is -93.78, creating a Neutral signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Price Rate of Change (ROC) is -57.89, creating a Sell signal.

FAQ

Is MRN3 a Buy, Hold, or Sell?
Based on MRN3’s technical indicators, MRN3 is a Sell.
    What is MRN3’s RSI (14)?
    MRN3’s RSI (14) is 35.04, which suggests MRN3 is a Neutral.
      What is MRN3’s MACD?
      MRN3’s MACD is -0.06, which suggests MRN3 is a Buy.
        What is MRN3’s 5-day moving average?
        MRN3’s 5-day moving average is 0.08, which suggests MRN3 is a Buy.
          What is MRN3’s 20-day moving average?
          MRN3 20-day moving average is 0.17, which suggests MRN3 is a Sell.
            What is MRN3’s 50-day moving average?
            MRN3’s 50-day moving average is 0.22, which suggests MRN3 is a Sell.
              What is MRN3’s 200-day moving average?
              MRN3’s 200-day moving average is 7.60, which suggests MRN3 is a Sell.
                What is MRN3’s Williams % R (14)?
                MRN3’s Williams % R (14) is -95.60, which suggests MRN3 is a Buy.
                  What is MRN3’s CCI (14)?
                  MRN3’s CCI (14) is -93.78, which suggests MRN3 is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis